DNA repair in resistance to bifunctional alkylating and platinating agents.
Murray
David
D
Department of Oncology, University of Alberta, Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
D000477:Alkylating Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D020137:Base Pair Mismatch; D004249:DNA Damage; D004260:DNA Repair; D019008:Drug Resistance, Neoplasm; D006801:Humans; D017671:Platinum Compounds / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000378:metabolism; D014466:Ultraviolet Rays
D000477:Alkylating Agents; D018906:Antineoplastic Agents, Alkylating; D017671:Platinum Compounds; D012333:RNA, Messenger